Kiora Pharmaceuticals Q4 EPS $(1.60) Misses $(0.67) Estimate

Kiora Pharmaceuticals (NASDAQ: KPRX) reported a Q4 loss of $(1.60) per share, missing the analyst consensus estimate of $(0.67) by 138.81%. This represents a 61.62% increase in losses compared to $(0.99) per share from the same period last year.